Cargando…
Case report: Pathological differences in pulmonary arterial hypertension in long-term responders to calcium channel blockers
BACKGROUND: This study investigates the pulmonary arterial histopathology in patients with idiopathic pulmonary arterial hypertension (IPAH) and acute vasoreactive phenotype, who demonstrated long-term survival (>30 years) and incidental death from causes other than PAH progression. The pathologi...
Autores principales: | Tamura, Yuichi, Lkhagvadorj, Sayamaa, Tamura, Yudai, Furukawa, Asuka, Aida, Shinsuke, Ebinuma, Hirotoshi, Shiomi, Takayuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10652395/ https://www.ncbi.nlm.nih.gov/pubmed/38028466 http://dx.doi.org/10.3389/fcvm.2023.1295718 |
Ejemplares similares
-
Case Report: BMPR2-Targeted MinION Sequencing as a Tool for Genetic Analysis in Patients With Pulmonary Arterial Hypertension
por: Takashima, Tomoya, et al.
Publicado: (2021) -
Safety of chronic high-dose calcium channel blockers exposure in children with pulmonary arterial hypertension
por: Wu, Yan, et al.
Publicado: (2022) -
Long‐term safety of a structured transition protocol from parenteral prostanoids to selexipag in pulmonary arterial hypertension
por: Tamura, Yuichi, et al.
Publicado: (2022) -
Usefulness of Global Longitudinal Strain-Guided Management in Preventing Human Epidermal Growth Factor Receptor 2 (HER2) Inhibitor-Induced Myocardial Damage
por: Yamada, Kenta, et al.
Publicado: (2022) -
Dasatinib-induced Pulmonary Hypertension
por: Tamura, Yudai, et al.
Publicado: (2022)